

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.82985437 |
| 2 | central nervous system myelination (GO:0022010) | 5.82985437 |
| 3 | fatty acid elongation (GO:0030497) | 4.88251292 |
| 4 | presynaptic membrane assembly (GO:0097105) | 4.82420700 |
| 5 | presynaptic membrane organization (GO:0097090) | 4.65016698 |
| 6 | sodium ion export (GO:0071436) | 4.46093714 |
| 7 | glutamate secretion (GO:0014047) | 4.39214814 |
| 8 | neuronal action potential propagation (GO:0019227) | 4.36859086 |
| 9 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.26185408 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.16328563 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 3.92423308 |
| 12 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.91606131 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.87463867 |
| 14 | regulation of cell communication by electrical coupling (GO:0010649) | 3.87184540 |
| 15 | myelination (GO:0042552) | 3.79907293 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.78902339 |
| 17 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.78405927 |
| 18 | axon ensheathment (GO:0008366) | 3.77193790 |
| 19 | ensheathment of neurons (GO:0007272) | 3.77193790 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.77010034 |
| 21 | cerebellar granule cell differentiation (GO:0021707) | 3.73370152 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.66224213 |
| 23 | synaptic vesicle maturation (GO:0016188) | 3.65479351 |
| 24 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.61616790 |
| 25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.52895729 |
| 26 | cell communication by electrical coupling (GO:0010644) | 3.50673546 |
| 27 | negative regulation of neurotransmitter transport (GO:0051589) | 3.50311418 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.47818693 |
| 29 | amino acid import (GO:0043090) | 3.47416626 |
| 30 | protein localization to synapse (GO:0035418) | 3.42846038 |
| 31 | potassium ion import (GO:0010107) | 3.42399594 |
| 32 | vocalization behavior (GO:0071625) | 3.41108811 |
| 33 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.40667399 |
| 34 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.38049217 |
| 35 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.37613934 |
| 36 | potassium ion homeostasis (GO:0055075) | 3.36641560 |
| 37 | L-amino acid import (GO:0043092) | 3.34378314 |
| 38 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.34300360 |
| 39 | positive regulation of dendritic spine development (GO:0060999) | 3.28816225 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25287902 |
| 41 | neuromuscular synaptic transmission (GO:0007274) | 3.22798505 |
| 42 | locomotory exploration behavior (GO:0035641) | 3.22610940 |
| 43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.22609352 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.21056171 |
| 45 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.20801011 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.20310359 |
| 47 | neuromuscular process controlling balance (GO:0050885) | 3.20221723 |
| 48 | transmission of nerve impulse (GO:0019226) | 3.17038436 |
| 49 | membrane depolarization during action potential (GO:0086010) | 3.14208844 |
| 50 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.12309887 |
| 51 | regulation of synaptic vesicle transport (GO:1902803) | 3.10119989 |
| 52 | L-phenylalanine catabolic process (GO:0006559) | 3.09618272 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.09618272 |
| 54 | cell communication involved in cardiac conduction (GO:0086065) | 3.07950169 |
| 55 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.06986713 |
| 56 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.06229923 |
| 57 | neuron-neuron synaptic transmission (GO:0007270) | 3.05722679 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 3.05336769 |
| 59 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.04481393 |
| 60 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.04454534 |
| 61 | cellular sodium ion homeostasis (GO:0006883) | 3.03901108 |
| 62 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.03302798 |
| 63 | detection of calcium ion (GO:0005513) | 2.99757052 |
| 64 | response to methylmercury (GO:0051597) | 2.99652492 |
| 65 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.99513591 |
| 66 | regulation of neurotransmitter levels (GO:0001505) | 2.96937886 |
| 67 | regulation of synapse structural plasticity (GO:0051823) | 2.96468855 |
| 68 | acidic amino acid transport (GO:0015800) | 2.93281398 |
| 69 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.92541618 |
| 70 | postsynaptic membrane organization (GO:0001941) | 2.92043626 |
| 71 | synaptic vesicle endocytosis (GO:0048488) | 2.90426761 |
| 72 | glutamate receptor signaling pathway (GO:0007215) | 2.90049524 |
| 73 | adult walking behavior (GO:0007628) | 2.88889003 |
| 74 | glycerophospholipid catabolic process (GO:0046475) | 2.86412418 |
| 75 | apical protein localization (GO:0045176) | 2.85771675 |
| 76 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.84432828 |
| 77 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83015557 |
| 78 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.81255414 |
| 79 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.80566442 |
| 80 | long-term synaptic potentiation (GO:0060291) | 2.78930294 |
| 81 | neuron recognition (GO:0008038) | 2.78669363 |
| 82 | neurotransmitter secretion (GO:0007269) | 2.77745696 |
| 83 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.77686340 |
| 84 | negative regulation of protein localization to cell surface (GO:2000009) | 2.77661972 |
| 85 | behavioral response to cocaine (GO:0048148) | 2.77620534 |
| 86 | positive regulation of membrane potential (GO:0045838) | 2.77467036 |
| 87 | regulation of membrane repolarization (GO:0060306) | 2.73244794 |
| 88 | regulation of synapse maturation (GO:0090128) | 2.72796400 |
| 89 | proline transport (GO:0015824) | 2.72648635 |
| 90 | neurotransmitter uptake (GO:0001504) | 2.72188608 |
| 91 | establishment of mitochondrion localization (GO:0051654) | 2.71705774 |
| 92 | layer formation in cerebral cortex (GO:0021819) | 2.71253610 |
| 93 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.69271494 |
| 94 | L-glutamate transport (GO:0015813) | 2.69216378 |
| 95 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.68001770 |
| 96 | very long-chain fatty acid metabolic process (GO:0000038) | 2.67800067 |
| 97 | cholesterol biosynthetic process (GO:0006695) | 2.67668209 |
| 98 | regulation of postsynaptic membrane potential (GO:0060078) | 2.66117259 |
| 99 | substantia nigra development (GO:0021762) | 2.65723275 |
| 100 | L-phenylalanine metabolic process (GO:0006558) | 2.65155517 |
| 101 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.65155517 |
| 102 | membrane depolarization (GO:0051899) | 2.64479624 |
| 103 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.62798112 |
| 104 | cardiac muscle contraction (GO:0060048) | 2.62729827 |
| 105 | C4-dicarboxylate transport (GO:0015740) | 2.62100017 |
| 106 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.62044050 |
| 107 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.60970326 |
| 108 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.60970326 |
| 109 | muscle filament sliding (GO:0030049) | 2.60419688 |
| 110 | actin-myosin filament sliding (GO:0033275) | 2.60419688 |
| 111 | relaxation of muscle (GO:0090075) | 2.60286746 |
| 112 | regulation of neurotransmitter secretion (GO:0046928) | 2.59764945 |
| 113 | membrane assembly (GO:0071709) | 2.59489907 |
| 114 | regulation of actin filament-based movement (GO:1903115) | 2.59178223 |
| 115 | regulation of synaptic plasticity (GO:0048167) | 2.58718260 |
| 116 | neuromuscular process (GO:0050905) | 2.57908524 |
| 117 | activation of protein kinase A activity (GO:0034199) | 2.57855797 |
| 118 | positive regulation of potassium ion transport (GO:0043268) | 2.57303025 |
| 119 | regulation of dendritic spine development (GO:0060998) | 2.54668102 |
| 120 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.54364345 |
| 121 | neuronal ion channel clustering (GO:0045161) | 2.54204890 |
| 122 | regulation of relaxation of muscle (GO:1901077) | 2.53590236 |
| 123 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.52859682 |
| 124 | mechanosensory behavior (GO:0007638) | 2.52673978 |
| 125 | neurotransmitter transport (GO:0006836) | 2.51189828 |
| 126 | dendritic spine morphogenesis (GO:0060997) | 2.50775386 |
| 127 | auditory behavior (GO:0031223) | 2.49288478 |
| 128 | oligodendrocyte differentiation (GO:0048709) | 2.48894439 |
| 129 | axonal fasciculation (GO:0007413) | 2.48205507 |
| 130 | thioester biosynthetic process (GO:0035384) | 2.46862057 |
| 131 | acyl-CoA biosynthetic process (GO:0071616) | 2.46862057 |
| 132 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.44984975 |
| 133 | cellular potassium ion homeostasis (GO:0030007) | 2.43266007 |
| 134 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.42662582 |
| 135 | negative regulation of axonogenesis (GO:0050771) | 2.42156784 |
| 136 | cellular response to epinephrine stimulus (GO:0071872) | 2.41960607 |
| 137 | myelin maintenance (GO:0043217) | 2.41553355 |
| 138 | regulation of glutamate secretion (GO:0014048) | 2.41490398 |
| 139 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.40471646 |
| 140 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.40267904 |
| 141 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.40246389 |
| 142 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.39953682 |
| 143 | dendrite morphogenesis (GO:0048813) | 2.39382777 |
| 144 | exploration behavior (GO:0035640) | 2.38118258 |
| 145 | neuron remodeling (GO:0016322) | 2.37027365 |
| 146 | regulation of neurotransmitter transport (GO:0051588) | 2.35893432 |
| 147 | membrane hyperpolarization (GO:0060081) | 2.35430579 |
| 148 | sterol biosynthetic process (GO:0016126) | 2.34839183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.00749370 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.82879337 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.80939846 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.71829870 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.69411695 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.52094989 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25306344 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25306344 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20034496 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.17096203 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14397625 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12237628 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12065891 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06763172 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04378819 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01400662 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96460208 |
| 18 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.94458140 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.93000356 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.90968646 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87790650 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87124541 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86586224 |
| 24 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.82327507 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81064547 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78421409 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72529250 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63542657 |
| 29 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62513937 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.62464581 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60199215 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56875437 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55925862 |
| 34 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53563041 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51337010 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50259355 |
| 37 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47548289 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44689113 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43069600 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43004684 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42268086 |
| 42 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.41427796 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40498116 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38292093 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36583438 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36371148 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35172667 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32496514 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31987398 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28036319 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27387590 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26416634 |
| 53 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26211166 |
| 54 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24724661 |
| 55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24413949 |
| 56 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.24339412 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24084905 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23916909 |
| 59 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.23757072 |
| 60 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21860692 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21813882 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19902882 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18621577 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17961945 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16868512 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.16095334 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15755604 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15755604 |
| 69 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.14103548 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12329837 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12088536 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11784003 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11313254 |
| 74 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10524603 |
| 75 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09988083 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09642772 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09637628 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09209234 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08805416 |
| 80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08711881 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08302752 |
| 82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07841692 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06889510 |
| 84 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03217215 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02035833 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01791646 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01249725 |
| 88 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01249725 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00766147 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00322614 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00086262 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99163285 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99131118 |
| 94 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98235056 |
| 95 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97975812 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97827229 |
| 97 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97767561 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97333736 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97246527 |
| 100 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97229490 |
| 101 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96796323 |
| 102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96598789 |
| 103 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.96430436 |
| 104 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.95944430 |
| 105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95200094 |
| 106 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94829006 |
| 107 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93867468 |
| 108 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.93519331 |
| 109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93288021 |
| 110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.92962904 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92537271 |
| 112 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92000199 |
| 113 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91963242 |
| 114 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91204149 |
| 115 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90769800 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90761934 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90225498 |
| 118 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89733881 |
| 119 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89357463 |
| 120 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89059004 |
| 121 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.88980264 |
| 122 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88523948 |
| 123 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87714788 |
| 124 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.87712152 |
| 125 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87676301 |
| 126 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.87651147 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86795852 |
| 128 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86735093 |
| 129 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86346101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.04304818 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.32352470 |
| 3 | MP0004270_analgesia | 3.78000484 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.09310693 |
| 5 | MP0009745_abnormal_behavioral_response | 2.91888246 |
| 6 | MP0002064_seizures | 2.90742059 |
| 7 | MP0000920_abnormal_myelination | 2.83143989 |
| 8 | MP0009046_muscle_twitch | 2.74479223 |
| 9 | MP0002272_abnormal_nervous_system | 2.67147453 |
| 10 | MP0003329_amyloid_beta_deposits | 2.66737241 |
| 11 | MP0001486_abnormal_startle_reflex | 2.57372645 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.45391722 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.30597355 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.25723105 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.22366298 |
| 16 | MP0004885_abnormal_endolymph | 2.20008005 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.19943659 |
| 18 | MP0003690_abnormal_glial_cell | 2.14611862 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.12427285 |
| 20 | MP0000749_muscle_degeneration | 1.89031044 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.88947927 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 1.83090238 |
| 23 | MP0001905_abnormal_dopamine_level | 1.82837445 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.78867839 |
| 25 | MP0001984_abnormal_olfaction | 1.75219803 |
| 26 | MP0000778_abnormal_nervous_system | 1.74967890 |
| 27 | MP0004142_abnormal_muscle_tone | 1.71771932 |
| 28 | MP0002736_abnormal_nociception_after | 1.70943231 |
| 29 | MP0004742_abnormal_vestibular_system | 1.70048641 |
| 30 | MP0001529_abnormal_vocalization | 1.67299782 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.60980410 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.59783057 |
| 33 | MP0004924_abnormal_behavior | 1.59783057 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.56116920 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.54902054 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.52784266 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.52516725 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.50993525 |
| 39 | MP0003195_calcinosis | 1.50122770 |
| 40 | MP0008569_lethality_at_weaning | 1.50055199 |
| 41 | MP0003646_muscle_fatigue | 1.49843027 |
| 42 | MP0001970_abnormal_pain_threshold | 1.46952339 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.46499876 |
| 44 | MP0003633_abnormal_nervous_system | 1.45368057 |
| 45 | MP0004147_increased_porphyrin_level | 1.45124522 |
| 46 | MP0000604_amyloidosis | 1.45103963 |
| 47 | MP0002735_abnormal_chemical_nociception | 1.44667662 |
| 48 | MP0005360_urolithiasis | 1.43723146 |
| 49 | MP0002229_neurodegeneration | 1.43365120 |
| 50 | MP0003631_nervous_system_phenotype | 1.37833209 |
| 51 | MP0000955_abnormal_spinal_cord | 1.35324061 |
| 52 | MP0005365_abnormal_bile_salt | 1.35209045 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.33848540 |
| 54 | MP0003632_abnormal_nervous_system | 1.30177369 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.30041630 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.29969061 |
| 57 | MP0003634_abnormal_glial_cell | 1.29219187 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.28705325 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.28248346 |
| 60 | MP0002822_catalepsy | 1.28179477 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.25374456 |
| 62 | MP0004043_abnormal_pH_regulation | 1.24702646 |
| 63 | MP0003879_abnormal_hair_cell | 1.20656298 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.18605367 |
| 65 | MP0005620_abnormal_muscle_contractility | 1.18474963 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.17307012 |
| 67 | MP0004084_abnormal_cardiac_muscle | 1.17093962 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.16076941 |
| 69 | MP0005171_absent_coat_pigmentation | 1.14643218 |
| 70 | MP0000579_abnormal_nail_morphology | 1.12135377 |
| 71 | MP0001963_abnormal_hearing_physiology | 1.11461181 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.11253741 |
| 73 | MP0000566_synostosis | 1.09173415 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.08025578 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 1.07594269 |
| 76 | MP0002184_abnormal_innervation | 1.05464786 |
| 77 | MP0005410_abnormal_fertilization | 1.04280622 |
| 78 | MP0004811_abnormal_neuron_physiology | 1.03835616 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.01297323 |
| 80 | MP0005670_abnormal_white_adipose | 0.99809693 |
| 81 | MP0003787_abnormal_imprinting | 0.94968918 |
| 82 | MP0003136_yellow_coat_color | 0.93962337 |
| 83 | MP0008874_decreased_physiological_sensi | 0.93866827 |
| 84 | MP0010329_abnormal_lipoprotein_level | 0.92729860 |
| 85 | MP0000759_abnormal_skeletal_muscle | 0.91441704 |
| 86 | MP0010030_abnormal_orbit_morphology | 0.91143291 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.90165481 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 0.87137689 |
| 89 | MP0002106_abnormal_muscle_physiology | 0.86723233 |
| 90 | MP0002152_abnormal_brain_morphology | 0.84924723 |
| 91 | MP0006276_abnormal_autonomic_nervous | 0.84543513 |
| 92 | MP0002269_muscular_atrophy | 0.83966464 |
| 93 | MP0008872_abnormal_physiological_respon | 0.83911660 |
| 94 | MP0005535_abnormal_body_temperature | 0.83798121 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.83360617 |
| 96 | MP0005409_darkened_coat_color | 0.82448411 |
| 97 | MP0005369_muscle_phenotype | 0.82205997 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.81702158 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.80717103 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.79889613 |
| 101 | MP0005332_abnormal_amino_acid | 0.79416069 |
| 102 | MP0001177_atelectasis | 0.78567429 |
| 103 | MP0002090_abnormal_vision | 0.77953183 |
| 104 | MP0005187_abnormal_penis_morphology | 0.77605104 |
| 105 | MP0000751_myopathy | 0.75805372 |
| 106 | MP0001188_hyperpigmentation | 0.75328492 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.75044010 |
| 108 | MP0003122_maternal_imprinting | 0.73967325 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.72197739 |
| 110 | MP0004484_altered_response_of | 0.71086072 |
| 111 | MP0005451_abnormal_body_composition | 0.71006826 |
| 112 | MP0005083_abnormal_biliary_tract | 0.70928200 |
| 113 | MP0000747_muscle_weakness | 0.70800358 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.70443256 |
| 115 | MP0009840_abnormal_foam_cell | 0.69825149 |
| 116 | MP0005499_abnormal_olfactory_system | 0.69523254 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.69523254 |
| 118 | MP0004036_abnormal_muscle_relaxation | 0.67915100 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.67638734 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.67299324 |
| 121 | MP0004085_abnormal_heartbeat | 0.67254145 |
| 122 | MP0006138_congestive_heart_failure | 0.67034523 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66819481 |
| 124 | MP0004858_abnormal_nervous_system | 0.63064086 |
| 125 | MP0004130_abnormal_muscle_cell | 0.62567600 |
| 126 | MP0000026_abnormal_inner_ear | 0.61404035 |
| 127 | MP0003868_abnormal_feces_composition | 0.61276127 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.59909873 |
| 129 | MP0002108_abnormal_muscle_morphology | 0.59876188 |
| 130 | MP0003283_abnormal_digestive_organ | 0.59636046 |
| 131 | MP0001664_abnormal_digestion | 0.58975109 |
| 132 | MP0000639_abnormal_adrenal_gland | 0.58938156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.73760676 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.98070771 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.98070771 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.66918118 |
| 5 | Hyperventilation (HP:0002883) | 4.48696160 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.38181189 |
| 7 | Myokymia (HP:0002411) | 4.36269312 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 4.29476264 |
| 9 | Nemaline bodies (HP:0003798) | 4.26575657 |
| 10 | Abnormality of the corticospinal tract (HP:0002492) | 4.20214572 |
| 11 | Atonic seizures (HP:0010819) | 4.16433942 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.08852040 |
| 13 | Focal seizures (HP:0007359) | 3.87084430 |
| 14 | Sensory axonal neuropathy (HP:0003390) | 3.81541268 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 3.76787923 |
| 16 | Cerebral inclusion bodies (HP:0100314) | 3.74580875 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 3.44025076 |
| 18 | Bundle branch block (HP:0011710) | 3.37851925 |
| 19 | Scanning speech (HP:0002168) | 3.33028363 |
| 20 | Spastic gait (HP:0002064) | 3.27390267 |
| 21 | Insidious onset (HP:0003587) | 3.24111220 |
| 22 | Termporal pattern (HP:0011008) | 3.24111220 |
| 23 | Dysmetria (HP:0001310) | 3.21016047 |
| 24 | Broad-based gait (HP:0002136) | 3.20403068 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 3.13945766 |
| 26 | Exercise-induced myalgia (HP:0003738) | 3.10616845 |
| 27 | Intention tremor (HP:0002080) | 3.07326096 |
| 28 | Absence seizures (HP:0002121) | 3.06855748 |
| 29 | Dialeptic seizures (HP:0011146) | 3.03187807 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 3.01848835 |
| 31 | Diplopia (HP:0000651) | 2.82357628 |
| 32 | Abnormality of binocular vision (HP:0011514) | 2.82357628 |
| 33 | Muscle fiber splitting (HP:0003555) | 2.77778554 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 2.77704591 |
| 35 | Peripheral hypomyelination (HP:0007182) | 2.76914943 |
| 36 | Generalized tonic-clonic seizures (HP:0002069) | 2.76499806 |
| 37 | Ankle clonus (HP:0011448) | 2.76039002 |
| 38 | Abnormality of glycolysis (HP:0004366) | 2.71950401 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.71950401 |
| 40 | Myotonia (HP:0002486) | 2.67219723 |
| 41 | Action tremor (HP:0002345) | 2.65369073 |
| 42 | Visual hallucinations (HP:0002367) | 2.63699182 |
| 43 | Poor eye contact (HP:0000817) | 2.63656879 |
| 44 | Febrile seizures (HP:0002373) | 2.63019953 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.56231051 |
| 46 | Pheochromocytoma (HP:0002666) | 2.55030788 |
| 47 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.52724051 |
| 48 | Dysdiadochokinesis (HP:0002075) | 2.49541856 |
| 49 | Sudden death (HP:0001699) | 2.48945777 |
| 50 | Parakeratosis (HP:0001036) | 2.47042318 |
| 51 | EMG: myopathic abnormalities (HP:0003458) | 2.44885093 |
| 52 | Distal arthrogryposis (HP:0005684) | 2.43568950 |
| 53 | Heart block (HP:0012722) | 2.41625852 |
| 54 | Intrahepatic cholestasis (HP:0001406) | 2.36672867 |
| 55 | Hyperlipoproteinemia (HP:0010980) | 2.34932970 |
| 56 | Abnormal social behavior (HP:0012433) | 2.32570553 |
| 57 | Impaired social interactions (HP:0000735) | 2.32570553 |
| 58 | Difficulty running (HP:0009046) | 2.31625440 |
| 59 | Onion bulb formation (HP:0003383) | 2.31494782 |
| 60 | Progressive cerebellar ataxia (HP:0002073) | 2.31188229 |
| 61 | Calf muscle hypertrophy (HP:0008981) | 2.30180310 |
| 62 | Akinesia (HP:0002304) | 2.28606758 |
| 63 | Urinary urgency (HP:0000012) | 2.28285869 |
| 64 | Generalized myoclonic seizures (HP:0002123) | 2.28019552 |
| 65 | Neuroendocrine neoplasm (HP:0100634) | 2.27547693 |
| 66 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.25664744 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.25078897 |
| 68 | Cholecystitis (HP:0001082) | 2.25078897 |
| 69 | Clumsiness (HP:0002312) | 2.23697580 |
| 70 | Cerebral hemorrhage (HP:0001342) | 2.21896924 |
| 71 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.19512779 |
| 72 | Retinal dysplasia (HP:0007973) | 2.17381960 |
| 73 | Abnormal atrioventricular conduction (HP:0005150) | 2.16174477 |
| 74 | Leukodystrophy (HP:0002415) | 2.15212696 |
| 75 | Mutism (HP:0002300) | 2.14422062 |
| 76 | Anxiety (HP:0000739) | 2.13650446 |
| 77 | Excessive salivation (HP:0003781) | 2.12777556 |
| 78 | Drooling (HP:0002307) | 2.12777556 |
| 79 | Lower limb muscle weakness (HP:0007340) | 2.12538200 |
| 80 | Rimmed vacuoles (HP:0003805) | 2.12295492 |
| 81 | Blue irides (HP:0000635) | 2.11847139 |
| 82 | Muscle stiffness (HP:0003552) | 2.09935902 |
| 83 | Thickened helices (HP:0000391) | 2.09403335 |
| 84 | Turricephaly (HP:0000262) | 2.07406889 |
| 85 | Frequent falls (HP:0002359) | 2.05750246 |
| 86 | Cerebral hypomyelination (HP:0006808) | 2.05106149 |
| 87 | Abnormality of the calf musculature (HP:0001430) | 2.04418842 |
| 88 | Methylmalonic acidemia (HP:0002912) | 2.04123223 |
| 89 | Inability to walk (HP:0002540) | 2.03639127 |
| 90 | Progressive inability to walk (HP:0002505) | 2.02422200 |
| 91 | Postural instability (HP:0002172) | 2.02245639 |
| 92 | Deep venous thrombosis (HP:0002625) | 2.02166073 |
| 93 | Limb dystonia (HP:0002451) | 2.01542646 |
| 94 | Lower limb amyotrophy (HP:0007210) | 2.00097346 |
| 95 | Epileptiform EEG discharges (HP:0011182) | 1.99338732 |
| 96 | Tetraplegia (HP:0002445) | 1.98077709 |
| 97 | Annular pancreas (HP:0001734) | 1.96657756 |
| 98 | Absent speech (HP:0001344) | 1.96308261 |
| 99 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94217793 |
| 100 | Torticollis (HP:0000473) | 1.94155116 |
| 101 | Poor speech (HP:0002465) | 1.94131260 |
| 102 | Myoglobinuria (HP:0002913) | 1.92309015 |
| 103 | Truncal ataxia (HP:0002078) | 1.92051526 |
| 104 | Abnormal eating behavior (HP:0100738) | 1.91303770 |
| 105 | Status epilepticus (HP:0002133) | 1.90876268 |
| 106 | Abnormality of the lower motor neuron (HP:0002366) | 1.87600439 |
| 107 | Sleep apnea (HP:0010535) | 1.87297397 |
| 108 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85994661 |
| 109 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.85672793 |
| 110 | Subaortic stenosis (HP:0001682) | 1.85672793 |
| 111 | Clonus (HP:0002169) | 1.85146798 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83520764 |
| 113 | Round ear (HP:0100830) | 1.82916603 |
| 114 | Xanthomatosis (HP:0000991) | 1.82719273 |
| 115 | Neck muscle weakness (HP:0000467) | 1.82264694 |
| 116 | Autoamputation (HP:0001218) | 1.81387647 |
| 117 | Calcaneovalgus deformity (HP:0001848) | 1.80804598 |
| 118 | Focal dystonia (HP:0004373) | 1.80438433 |
| 119 | Impaired vibratory sensation (HP:0002495) | 1.80277921 |
| 120 | Abnormality of saccadic eye movements (HP:0000570) | 1.79978666 |
| 121 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78916353 |
| 122 | Spastic tetraparesis (HP:0001285) | 1.78638363 |
| 123 | Acute encephalopathy (HP:0006846) | 1.78468763 |
| 124 | Slow saccadic eye movements (HP:0000514) | 1.77867286 |
| 125 | Spastic paraparesis (HP:0002313) | 1.77452098 |
| 126 | Craniofacial dystonia (HP:0012179) | 1.77182976 |
| 127 | Prolonged partial thromboplastin time (HP:0003645) | 1.76929658 |
| 128 | Fair hair (HP:0002286) | 1.76414926 |
| 129 | Abnormality of the foot musculature (HP:0001436) | 1.76036693 |
| 130 | Acute necrotizing encephalopathy (HP:0006965) | 1.75930967 |
| 131 | Syncope (HP:0001279) | 1.73451377 |
| 132 | Rapidly progressive (HP:0003678) | 1.73295477 |
| 133 | Hemiparesis (HP:0001269) | 1.73187131 |
| 134 | Atrioventricular block (HP:0001678) | 1.73112434 |
| 135 | EMG: neuropathic changes (HP:0003445) | 1.72882723 |
| 136 | Hypsarrhythmia (HP:0002521) | 1.72353144 |
| 137 | Fetal akinesia sequence (HP:0001989) | 1.71947810 |
| 138 | Depression (HP:0000716) | 1.71694591 |
| 139 | Split foot (HP:0001839) | 1.71317813 |
| 140 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70848003 |
| 141 | Absent/shortened dynein arms (HP:0200106) | 1.70441300 |
| 142 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70441300 |
| 143 | Aplasia involving bones of the extremities (HP:0009825) | 1.70105092 |
| 144 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.70105092 |
| 145 | Aplasia of the phalanges of the hand (HP:0009802) | 1.70105092 |
| 146 | Amblyopia (HP:0000646) | 1.70095707 |
| 147 | Foot dorsiflexor weakness (HP:0009027) | 1.70036138 |
| 148 | Atrial fibrillation (HP:0005110) | 1.69950636 |
| 149 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.69915260 |
| 150 | Hemiplegia (HP:0002301) | 1.68936512 |
| 151 | Incomplete penetrance (HP:0003829) | 1.67989513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.10921864 |
| 2 | OXSR1 | 3.93120059 |
| 3 | STK39 | 3.78135471 |
| 4 | EPHA4 | 3.70654462 |
| 5 | CDK19 | 3.54903923 |
| 6 | OBSCN | 3.21191539 |
| 7 | DAPK2 | 2.69715484 |
| 8 | TNIK | 2.48068656 |
| 9 | NTRK3 | 2.21746068 |
| 10 | MAP3K4 | 2.17076710 |
| 11 | LATS2 | 1.99444257 |
| 12 | MAP2K7 | 1.94647495 |
| 13 | MAP3K9 | 1.94577399 |
| 14 | PAK6 | 1.89962635 |
| 15 | PRPF4B | 1.71473723 |
| 16 | MARK1 | 1.69962635 |
| 17 | NTRK1 | 1.59957991 |
| 18 | MAP2K4 | 1.54214271 |
| 19 | CCNB1 | 1.48732803 |
| 20 | PKN1 | 1.45351160 |
| 21 | WNK4 | 1.44973108 |
| 22 | BCR | 1.44286325 |
| 23 | FGFR2 | 1.38825913 |
| 24 | PNCK | 1.38596788 |
| 25 | MAPKAPK5 | 1.38365021 |
| 26 | SGK223 | 1.32079455 |
| 27 | SGK494 | 1.32079455 |
| 28 | PLK2 | 1.31558502 |
| 29 | CAMK2B | 1.31219626 |
| 30 | UHMK1 | 1.31155209 |
| 31 | MINK1 | 1.31049604 |
| 32 | CDK5 | 1.28144692 |
| 33 | WNK1 | 1.27186366 |
| 34 | EPHB1 | 1.26274386 |
| 35 | TTN | 1.22829257 |
| 36 | KSR2 | 1.17550864 |
| 37 | ARAF | 1.13494662 |
| 38 | NEK6 | 1.12629269 |
| 39 | CSNK1G2 | 1.10597294 |
| 40 | CAMK2A | 1.09704259 |
| 41 | RIPK1 | 1.08243113 |
| 42 | CAMKK2 | 1.03798231 |
| 43 | CSNK1G3 | 1.03554122 |
| 44 | RIPK4 | 1.01498683 |
| 45 | NTRK2 | 1.01113076 |
| 46 | DAPK1 | 1.01000258 |
| 47 | GRK5 | 0.98823897 |
| 48 | MAPK13 | 0.98453429 |
| 49 | CAMK2D | 0.98398682 |
| 50 | MET | 0.96761374 |
| 51 | MAP3K12 | 0.96423514 |
| 52 | ROCK2 | 0.94350761 |
| 53 | TYRO3 | 0.93465653 |
| 54 | FGR | 0.92700773 |
| 55 | CSNK1A1L | 0.92641971 |
| 56 | DMPK | 0.91711179 |
| 57 | PAK3 | 0.90544258 |
| 58 | CDK14 | 0.88182707 |
| 59 | MUSK | 0.87974345 |
| 60 | CAMK2G | 0.87590743 |
| 61 | PHKG2 | 0.85731645 |
| 62 | PHKG1 | 0.85731645 |
| 63 | PRKCG | 0.84582457 |
| 64 | CDK15 | 0.84407175 |
| 65 | ICK | 0.84203466 |
| 66 | CDK18 | 0.83550574 |
| 67 | BMPR2 | 0.82917063 |
| 68 | PINK1 | 0.82593561 |
| 69 | PDPK1 | 0.82454447 |
| 70 | CAMKK1 | 0.78524986 |
| 71 | MARK2 | 0.76130065 |
| 72 | MAP3K13 | 0.76043648 |
| 73 | MAPK7 | 0.74553240 |
| 74 | CDK11A | 0.72749846 |
| 75 | ADRBK2 | 0.70403589 |
| 76 | PBK | 0.70284690 |
| 77 | MAPK12 | 0.69972690 |
| 78 | STK11 | 0.69603981 |
| 79 | CSNK1G1 | 0.68774348 |
| 80 | MAP3K2 | 0.68119766 |
| 81 | CDC7 | 0.67684618 |
| 82 | MAPK10 | 0.67279400 |
| 83 | PRKCE | 0.65482543 |
| 84 | CAMK1 | 0.65372557 |
| 85 | PTK2B | 0.65160139 |
| 86 | BRAF | 0.64658741 |
| 87 | PDK1 | 0.64115154 |
| 88 | RPS6KA3 | 0.63922159 |
| 89 | KSR1 | 0.63177271 |
| 90 | CAMK4 | 0.62863950 |
| 91 | DAPK3 | 0.58252877 |
| 92 | MOS | 0.56156889 |
| 93 | AKT3 | 0.54632647 |
| 94 | ALK | 0.53824597 |
| 95 | LIMK1 | 0.52505812 |
| 96 | ROCK1 | 0.52237126 |
| 97 | PRKD3 | 0.51745001 |
| 98 | SGK3 | 0.51520809 |
| 99 | ERBB4 | 0.51262879 |
| 100 | BCKDK | 0.50326145 |
| 101 | SGK1 | 0.50200355 |
| 102 | CAMK1G | 0.49136813 |
| 103 | FES | 0.48901643 |
| 104 | DDR2 | 0.48243099 |
| 105 | RET | 0.46670308 |
| 106 | PIK3CA | 0.45066631 |
| 107 | TTK | 0.45008035 |
| 108 | PRKCH | 0.44993457 |
| 109 | PDK3 | 0.43882330 |
| 110 | PDK4 | 0.43882330 |
| 111 | PRKCQ | 0.43075941 |
| 112 | FYN | 0.43065941 |
| 113 | PRKACA | 0.42022003 |
| 114 | PRKG1 | 0.41652755 |
| 115 | DYRK1A | 0.41196604 |
| 116 | RAF1 | 0.39934173 |
| 117 | SGK2 | 0.39684927 |
| 118 | PLK3 | 0.39464444 |
| 119 | CSNK1E | 0.39168467 |
| 120 | PRKACB | 0.38819273 |
| 121 | PDK2 | 0.38563335 |
| 122 | NEK1 | 0.37363194 |
| 123 | STK38L | 0.36343367 |
| 124 | PAK2 | 0.36035396 |
| 125 | AKT2 | 0.35360475 |
| 126 | PRKCA | 0.34814800 |
| 127 | STK38 | 0.34595053 |
| 128 | PRKG2 | 0.33365859 |
| 129 | TIE1 | 0.33091225 |
| 130 | PRKDC | 0.32154608 |
| 131 | CSNK1A1 | 0.31604591 |
| 132 | GSK3B | 0.29025740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.55927872 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.40102785 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.38129240 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.35901743 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.25483739 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.24256072 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.21518255 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.06856525 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.93819151 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.88504407 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.88209031 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85350510 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.78286074 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.77365145 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69674736 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.68119398 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.64657286 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.53117696 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50903764 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.50255664 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.49217969 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.49176241 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48004808 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45983296 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45336836 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.31758678 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31704676 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29582222 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.25632822 |
| 30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25336925 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24621891 |
| 32 | Melanogenesis_Homo sapiens_hsa04916 | 1.24621664 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24621182 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21365562 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.21015965 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19993028 |
| 37 | Circadian rhythm_Homo sapiens_hsa04710 | 1.19524033 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.17390672 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.14428036 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12816529 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11113203 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11022994 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.10675315 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08855139 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08460045 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08350324 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08223966 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06229253 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.05933951 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05207869 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.05123262 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.02761515 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02629616 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01691071 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00452563 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99385831 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97553242 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97106046 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94753378 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.94632856 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94164116 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 0.93974430 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93564843 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.91423494 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91348527 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89140563 |
| 67 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87521589 |
| 68 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87048416 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86845087 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85005053 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84952544 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83725631 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82007674 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80736576 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80129295 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78457041 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75273512 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74113176 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.73657676 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72959176 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70369498 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70180586 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.70125640 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67874631 |
| 85 | Gap junction_Homo sapiens_hsa04540 | 0.67646854 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66353754 |
| 87 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65247195 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64661898 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63381372 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62737269 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61727332 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60603616 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59975478 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59353740 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59050254 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59015628 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58654960 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56526457 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.55595793 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55321085 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54979343 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52860051 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52803446 |
| 104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52689154 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52622337 |
| 106 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51270958 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50222652 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50207953 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48936593 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48917439 |
| 111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48646601 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47745161 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47219987 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46695450 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45016486 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44461126 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44404916 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44068565 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42864890 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.41501748 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41185444 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40986069 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40573729 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38706414 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.38628969 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37826984 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36935591 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36300152 |

